000 | 01316 a2200337 4500 | ||
---|---|---|---|
005 | 20250517233442.0 | ||
264 | 0 | _c20191107 | |
008 | 201911s 0 0 eng d | ||
022 | _a2325-6621 | ||
024 | 7 |
_a10.1513/AnnalsATS.201806-400PP _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchatz, Michael | |
245 | 0 | 0 |
_aImplications of Changes in U.S. Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy. _h[electronic resource] |
260 |
_bAnnals of the American Thoracic Society _c10 2018 |
||
300 |
_a1131-1136 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnti-Asthmatic Agents _xpharmacology |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 |
_aBiological Products _xpharmacology |
650 | 0 | 4 |
_aDrug Prescriptions _xstandards |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications _xdrug therapy |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aKrishnan, Jerry A | |
700 | 1 | _aChambers, Christina | |
773 | 0 |
_tAnnals of the American Thoracic Society _gvol. 15 _gno. 10 _gp. 1131-1136 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1513/AnnalsATS.201806-400PP _zAvailable from publisher's website |
999 |
_c28752206 _d28752206 |